AllianceBernstein’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-162,790
| Closed | -$553K | – | 3164 |
|
|
2018
Q3 | $553K | Sell |
162,790
-4,520
| -3% | -$15.4K | ﹤0.01% | 2563 |
|
|
2018
Q2 | $629K | Buy |
167,310
+13,960
| +9% | +$52.5K | ﹤0.01% | 2516 |
|
|
2018
Q1 | $627K | Buy |
153,350
+15,200
| +11% | +$62.1K | ﹤0.01% | 2441 |
|
|
2017
Q4 | $642K | Buy |
138,150
+510
| +0.4% | +$2.37K | ﹤0.01% | 2455 |
|
|
2017
Q3 | $977K | Sell |
137,640
-54,010
| -28% | -$383K | ﹤0.01% | 2280 |
|
|
2017
Q2 | $1.39M | Buy |
191,650
+54,010
| +39% | +$391K | ﹤0.01% | 2092 |
|
|
2017
Q1 | $848K | Sell |
137,640
-11,700
| -8% | -$72.1K | ﹤0.01% | 2306 |
|
|
2016
Q4 | $875K | Hold |
149,340
| – | – | ﹤0.01% | 2302 |
|
|
2016
Q3 | $793K | Sell |
149,340
-11,700
| -7% | -$62.1K | ﹤0.01% | 2322 |
|
|
2016
Q2 | $1.07M | Hold |
161,040
| – | – | ﹤0.01% | 2174 |
|
|
2016
Q1 | $752K | Sell |
161,040
-15,500
| -9% | -$72.4K | ﹤0.01% | 2248 |
|
|
2015
Q4 | $892K | Hold |
176,540
| – | – | ﹤0.01% | 2191 |
|
|
2015
Q3 | $621K | Sell |
176,540
-160
| -0.1% | -$563 | ﹤0.01% | 2396 |
|
|
2015
Q2 | $1.76M | Sell |
176,700
-1,600
| -0.9% | -$16K | ﹤0.01% | 1895 |
|
|
2015
Q1 | $2.27M | Buy |
178,300
+1,600
| +0.9% | +$20.4K | ﹤0.01% | 1625 |
|
|
2014
Q4 | $2.5M | Sell |
176,700
-5,600
| -3% | -$79.2K | ﹤0.01% | 1575 |
|
|
2014
Q3 | $2.51M | Hold |
182,300
| – | – | ﹤0.01% | 1536 |
|
|
2014
Q2 | $2.8M | Buy |
182,300
+30,700
| +20% | +$472K | ﹤0.01% | 1514 |
|
|
2014
Q1 | $2.58M | Sell |
151,600
-239
| -0.2% | -$4.07K | ﹤0.01% | 1507 |
|
|
2013
Q4 | $1.97M | Buy |
151,839
+2,037
| +1% | +$26.4K | ﹤0.01% | 1709 |
|
|
2013
Q3 | $1.51M | Buy |
149,802
+2
| +0% | +$20 | ﹤0.01% | 1871 |
|
|
2013
Q2 | $1.12M | Buy |
+149,800
| New | +$1.12M | ﹤0.01% | 2005 |
|